A detailed history of Charles Schwab Investment Management Inc transactions in Sera Prognostics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 77,113 shares of SERA stock, worth $626,928. This represents 0.0% of its overall portfolio holdings.

Number of Shares
77,113
Previous 77,113 -0.0%
Holding current value
$626,928
Previous $456,000 31.8%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$5.6 - $11.69 $364,632 - $761,170
65,113 Added 542.61%
77,113 $456,000
Q1 2023

May 11, 2023

BUY
$1.19 - $4.25 $14,280 - $51,000
12,000 New
12,000 $45,000
Q2 2022

Aug 15, 2022

SELL
$1.2 - $3.62 $21,292 - $64,233
-17,744 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$2.96 - $8.8 $52,522 - $156,147
17,744 New
17,744 $68,000

Others Institutions Holding SERA

About SERA PROGNOSTICS, INC.


  • Ticker SERA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 29,596,900
  • Market Cap $241M
  • Description
  • Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...
More about SERA
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.